O
MRUS

OrbiMed’s Merus MRUS Stock Holding History

OrbiMed’s Portfolio MRUS Stock Details MRUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-156,100
Closed -$9.24M – 128
2024
Q2 		$9.24M Buy
+156,100
New +$7.56M 0.18% 77

Other funds holding MRUS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

OrbiMed's MRUS Position: Q3 2024 in Review

OrbiMed sold out of Merus (MRUS) in Q3 2024, closing a stake of 156,100 shares — an estimated $9.24M sold.

OrbiMed first reported a position in MRUS in Q2 2024 and held it in 1 quarter. The position peaked at $9.24M in Q2 2024. 189 funds tracked by Wall St. Rank hold MRUS as of Q3 2024.

  • OrbiMed reported no remaining Merus position as of Q3 2024 after selling out during the quarter.
  • OrbiMed sold 156,100 Merus shares in Q3 2024, an estimated $9.24M.
  • OrbiMed first reported a position in Merus in Q2 2024 and held it in 1 quarter.
  • OrbiMed's Merus position peaked at $9.24M in Q2 2024.
  • 189 funds tracked by Wall St. Rank held Merus as of Q3 2024.

Based on OrbiMed's 13F filing for Q3 2024, filed 14 Nov 2024.